StockMacro
Menu

Zoetis

$79.11 -1.4% in 6 monthsMarket cap $32.1B

ZTS on XNYS, Health Care, ZOETIS INC., job postings

Measures activity, not value. Not investment advice.

Shares fell 32% in a year while profit slipped 5.5% to $2.5B on flat revenue.

  • BadForeign specialist hiring applications fell 62% to 52 in 12 months

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Industry
Pharmaceutical preparations (Health Care)
Employees
14,500
Website
zoetis.com
Listed
NYSE, US
Last results
5 Nov 2026
Next results
expected around 11 Feb 2027 (an estimate: a year ago it reported on 12 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $2.4B, net income $591.0M.
Quarter to 31 Dec 2021: revenue $2.0B, net income $414.0MQuarter to 31 Dec 2021: revenue $2.0B, net income $414.0MQuarter to 31 Mar 2022: revenue $2.0B, net income $595.0MQuarter to 31 Mar 2022: revenue $2.0B, net income $595.0MQuarter to 30 Jun 2022: revenue $2.1B, net income $529.0MQuarter to 30 Jun 2022: revenue $2.1B, net income $529.0MQuarter to 30 Sep 2022: revenue $2.0B, net income $529.0MQuarter to 30 Sep 2022: revenue $2.0B, net income $529.0MQuarter to 31 Dec 2022: revenue $2.0B, net income $461.0MQuarter to 31 Dec 2022: revenue $2.0B, net income $461.0MQuarter to 31 Mar 2023: revenue $2.0B, net income $552.0MQuarter to 31 Mar 2023: revenue $2.0B, net income $552.0MQuarter to 30 Jun 2023: revenue $2.2B, net income $671.0MQuarter to 30 Jun 2023: revenue $2.2B, net income $671.0MQuarter to 30 Sep 2023: revenue $2.2B, net income $596.0MQuarter to 30 Sep 2023: revenue $2.2B, net income $596.0MQuarter to 31 Dec 2023: revenue $2.2B, net income $525.0MQuarter to 31 Dec 2023: revenue $2.2B, net income $525.0MQuarter to 31 Mar 2024: revenue $2.2B, net income $599.0MQuarter to 31 Mar 2024: revenue $2.2B, net income $599.0MQuarter to 30 Jun 2024: revenue $2.4B, net income $624.0MQuarter to 30 Jun 2024: revenue $2.4B, net income $624.0MQuarter to 30 Sep 2024: revenue $2.4B, net income $682.0MQuarter to 30 Sep 2024: revenue $2.4B, net income $682.0MQuarter to 31 Dec 2024: revenue $2.3B, net income $581.0MQuarter to 31 Dec 2024: revenue $2.3B, net income $581.0MQuarter to 31 Mar 2025: revenue $2.2B, net income $631.0MQuarter to 31 Mar 2025: revenue $2.2B, net income $631.0MQuarter to 30 Jun 2025: revenue $2.5B, net income $718.0MQuarter to 30 Jun 2025: revenue $2.5B, net income $718.0MQuarter to 30 Sep 2025: revenue $2.4B, net income $721.0MQuarter to 30 Sep 2025: revenue $2.4B, net income $721.0MQuarter to 31 Dec 2025: revenue $2.4B, net income $603.0MQuarter to 31 Dec 2025: revenue $2.4B, net income $603.0MQuarter to 31 Mar 2026: revenue $2.3B, net income $601.0MQuarter to 31 Mar 2026: revenue $2.3B, net income $601.0MQuarter to 30 Jun 2026: revenue $2.5B, net income $691.0MQuarter to 30 Jun 2026: revenue $2.5B, net income $691.0MQuarter to 30 Sep 2026: revenue $2.4B, net income $591.0MQuarter to 30 Sep 2026: revenue $2.4B, net income $591.0M
31 Dec 2021RevenueNet incometallest bar $2.5B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$2.4B$591.0M
30 Jun 2026$2.5B$691.0M
31 Mar 2026$2.3B$601.0M
31 Dec 2025$2.4B$603.0M
30 Sep 2025$2.4B$721.0M
30 Jun 2025$2.5B$718.0M
31 Mar 2025$2.2B$631.0M
31 Dec 2024$2.3B$581.0M
30 Sep 2024$2.4B$682.0M
30 Jun 2024$2.4B$624.0M
31 Mar 2024$2.2B$599.0M
31 Dec 2023$2.2B$525.0M
30 Sep 2023$2.2B$596.0M
30 Jun 2023$2.2B$671.0M
31 Mar 2023$2.0B$552.0M
31 Dec 2022$2.0B$461.0M
30 Sep 2022$2.0B$529.0M
30 Jun 2022$2.1B$529.0M
31 Mar 2022$2.0B$595.0M
31 Dec 2021$2.0B$414.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $9.5B $9.4B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +1.0% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $2.5B $2.6B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $5.88 $5.89
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 71.4% 71.5% 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 26.1% 27.9% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 57.1% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – $2.1B
CashCash, cash equivalents and short-term investments on the latest balance sheet. $1.5B $2.1B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $9.0B $7.1B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $7.5B $5.0B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 2.7 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $8.13
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 12.9 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 3.4 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 4.2 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 9.7 2.0
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 2.6% 2.5%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
ZoetisZTS (this company) $32.1B12.93.4+1.0%26.1%
InsmedINSM $31.0Bloss20.4+240%-39.9%
Royalty PharmaRPRX $30.5B45.411.6+11%25.7%
Roivant SciencesROIV $28.0Bloss682–-838%
United TherapeuticsUTHR $23.6B19.27.4+1.9%38.6%
Teva Pharmaceutical IndustriesTEVA $45.8B90.53.3-16%3.6%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-4.3%

1,341 13F filers vs 1,401

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

93%

376.5M shares held by 13F filers (30 Sep 2026) of 406.3M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.1%

16.7M shares sold short (30 Oct 2026) of 406.3M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.8

16.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-4.5%

17.5M shares sold short in the report before, 16.7M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

26%

26% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 46%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-62%

52 vs 137 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-0.4%

$2.4B vs $2.4B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-20%

$107.0M vs $133.0M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$1.3M

the 12 months before: $548K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$150K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

34

34 articles in the last 7 days; its usual week has 7 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

4.9×

34 articles in the last 7 days; its usual week has 7.

Price $79.11 on 20 Nov 2026, -32% over 12 months (12-month range $69.10 to $131.10)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $1.7M in the last 12 months (the 12 months before: -$483K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 52 published in the last 12 months, -62% on the 12 months before.
Revenue per quarter. Revenue $2.4B in the latest quarter, -0.4% on a year earlier.
Capital spending per quarter. Capital spending $107.0M in the latest quarter, -20% on a year earlier.
Institutional holders (13F filers). 1,341 13F filers reported holding it in the latest 13F quarter, -22% on a year earlier.
Federal obligations. Federal obligations: $1.2M published in the last 12 months, +110% on the 12 months before.
Lobbying spend. Lobbying spend: $150K published in the last 12 months (none in the 12 months before).

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
13 Oct 20268-K and other filingsDirector or officer change
6 Aug 20268-K and other filingsDirector or officer change
21 May 20268-K and other filingsDirector or officer change
21 May 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 May 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 886K)
17 Mar 2026Sharp changeShort interest spike: short interest spike, 17.3M vs usual 8.9M (2026-02-27); 2.7x the same period a year earlier
3 Mar 2026Sharp changeShort interest spike: short interest spike, 16.3M vs usual 8.7M (2026-02-13); 2.0x the same period a year earlier
17 Feb 2026Sharp changeShort interest spike: short interest spike, 14.1M vs usual 8.6M (2026-01-30); 1.6x the same period a year earlier
3 Feb 2026Sharp changeShort interest spike: short interest spike, 15.6M vs usual 8.4M (2026-01-15); 2.2x the same period a year earlier
13 Jan 2026Sharp changeShort interest spike: short interest spike, 13.7M vs usual 8.2M (2025-12-31); 2.0x the same period a year earlier
28 Oct 20258-K and other filingsDirector or officer change
28 Oct 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Aug 20258-K and other filingsA major agreement ended
22 May 20258-K and other filingsDirector or officer change
22 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jul 2024Sharp changeShort interest spike: short interest spike, 6.2M vs usual 3.5M (2024-06-28); 2.5x the same period a year earlier
2 Jul 2024Sharp changeShort interest spike: short interest spike, 6.9M vs usual 3.4M (2024-06-14); 2.2x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 5.8M vs usual 3.4M (2024-05-31); 1.6x the same period a year earlier
28 May 2024Sharp changeShort interest spike: short interest spike, 6.0M vs usual 3.4M (2024-05-15); 1.6x the same period a year earlier
24 May 20248-K and other filingsDirector or officer change
23 May 20248-K and other filingsDirector or officer change
14 May 2024Sharp changeShort interest spike: short interest spike, 5.2M vs usual 3.4M (2024-04-30); 1.1x the same period a year earlier
16 Apr 20248-K and other filingsDirector or officer change
1 Apr 20248-K and other filingsDirector or officer change
1 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 May 2023Sharp changeMany funds opening a new position: many funds opening a new position, 125 vs usual 87 (2023-03-31); 1.2x the same period a year earlier
7 Feb 20238-K and other filingsDirector or officer change
7 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Dec 20228-K and other filingsA major agreement ended
15 Dec 2022Lobbying filinglobbying engagement terminated (INVARIANT LLC)
25 Oct 20228-K and other filingsDirector or officer change
25 Oct 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Oct 2022Sharp changeH-1B/E-3 applications change: h-1B/E-3 applications change, 20 vs usual 7.50 in the same month of earlier years (2022-05-01..2022-05-31); 2.2x the same month a year earlier
25 Jul 20228-K and other filingsDirector or officer change
25 Jul 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Jul 2022Sharp changeLobbying on a new issue: lobbying on a new issue: ENV (2022-06-30)
21 Apr 20228-K and other filingsDirector or officer change
21 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Nov 2021: -$3.5M published
Month from 1 Dec 2021: -$318K published
Month from 1 Feb 2022: -$6.6M published
Month from 1 Mar 2022: -$3.1M published
Month from 1 Apr 2022: -$388K published
Month from 1 Jun 2022: -$1.1M published
Month from 1 Jul 2022: -$2.2M published
Month from 1 Aug 2022: -$192K published
Month from 1 Feb 2023: -$2.3M published
Month from 1 Apr 2023: -$763K published
Month from 1 May 2023: -$2.3M published
Month from 1 Aug 2023: -$2.6M published
Month from 1 Sep 2023: -$2.1M published
Month from 1 Oct 2023: -$160K published
Month from 1 Nov 2023: -$2.5M published
Month from 1 Dec 2023: -$683K published
Month from 1 Jan 2024: -$177K published
Month from 1 Feb 2024: -$3.2M published
Month from 1 Mar 2024: -$410K published
Month from 1 Apr 2024: -$140K published
Month from 1 Nov 2024: -$617K published
Month from 1 Feb 2025: -$116K published
Month from 1 Mar 2025: -$256K published
Month from 1 Jun 2025: -$111K published
Month from 1 Feb 2026: -$2.5M published
Month from 1 May 2026: $886K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 12 published
Quarter from 1 Apr 2022: 31 published
Quarter from 1 Jul 2022: 62 published
Quarter from 1 Oct 2022: 22 published
Quarter from 1 Jan 2023: 13 published
Quarter from 1 Apr 2023: 23 published
Quarter from 1 Jul 2023: 39 published
Quarter from 1 Oct 2023: 15 published
Quarter from 1 Jan 2024: 10 published
Quarter from 1 Apr 2024: 7 published
Quarter from 1 Jul 2024: 53 published
Quarter from 1 Oct 2024: 11 published
Quarter from 1 Jan 2025: 15 published
Quarter from 1 Apr 2025: 55 published
Quarter from 1 Jul 2025: 57 published
Quarter from 1 Oct 2025: 10 published
Quarter from 1 Jan 2026: 6 published
Quarter from 1 Apr 2026: 11 published
Quarter from 1 Jul 2026: 31 published
Quarter from 1 Oct 2026: 4 published
Revenue per quarter
Quarter ended 31 Dec 2021: $2.0B, +8.9% on a year earlier; public on 16 Feb 2022
Quarter ended 31 Mar 2022: $2.0B, +6.1% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $2.1B, +5.3% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $2.0B, +0.6% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $2.0B, +3.7% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $2.0B, +0.7% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $2.2B, +6.2% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $2.2B, +7.4% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $2.2B, +8.5% on a year earlier; public on 14 Feb 2024
Quarter ended 31 Mar 2024: $2.2B, +9.5% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $2.4B, +8.3% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $2.4B, +11% on a year earlier; public on 5 Nov 2024
Quarter ended 31 Dec 2024: $2.3B, +4.7% on a year earlier; public on 14 Feb 2025
Quarter ended 31 Mar 2025: $2.2B, +1.4% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $2.5B, +4.2% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $2.4B, +0.5% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $2.4B, +3.0% on a year earlier; public on 13 Feb 2026
Quarter ended 31 Mar 2026: $2.3B, +1.9% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $2.5B, +0.3% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $2.4B, -0.4% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $168.0M, +11% on a year earlier; public on 16 Feb 2022
Quarter ended 31 Mar 2022: $115.0M, +49% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $146.0M, +29% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $154.0M, +29% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $171.0M, +1.8% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $223.0M, +94% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $166.0M, +14% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $145.0M, -5.8% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $198.0M, +16% on a year earlier; public on 14 Feb 2024
Quarter ended 31 Mar 2024: $140.0M, -37% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $132.0M, -20% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $167.0M, +15% on a year earlier; public on 5 Nov 2024
Quarter ended 31 Dec 2024: $216.0M, +9.1% on a year earlier; public on 14 Feb 2025
Quarter ended 31 Mar 2025: $149.0M, +6.4% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $178.0M, +35% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $133.0M, -20% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $161.0M, -25% on a year earlier; public on 13 Feb 2026
Quarter ended 31 Mar 2026: $110.0M, -26% on a year earlier; public on 8 May 2026
Quarter ended 30 Sep 2026: $107.0M, -20% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 1,472; public on 14 Feb 2022
31 Mar 2022 report: 1,522; public on 16 May 2022
30 Jun 2022 report: 1,456; public on 15 Aug 2022
30 Sep 2022 report: 1,372; public on 14 Nov 2022
31 Dec 2022 report: 1,381; public on 14 Feb 2023
31 Mar 2023 report: 1,445; public on 15 May 2023
30 Jun 2023 report: 1,480; public on 14 Aug 2023
30 Sep 2023 report: 1,490; public on 14 Nov 2023
31 Dec 2023 report: 1,604; public on 14 Feb 2024
31 Mar 2024 report: 1,640; public on 15 May 2024
30 Jun 2024 report: 1,639; public on 14 Aug 2024
30 Sep 2024 report: 1,685; public on 14 Nov 2024
31 Dec 2024 report: 1,765; public on 14 Feb 2025
31 Mar 2025 report: 1,786; public on 15 May 2025
30 Jun 2025 report: 1,782; public on 14 Aug 2025
30 Sep 2025 report: 1,711; public on 14 Nov 2025
31 Dec 2025 report: 1,619; public on 17 Feb 2026
31 Mar 2026 report: 1,564; public on 15 May 2026
30 Jun 2026 report: 1,401; public on 14 Aug 2026
30 Sep 2026 report: 1,341; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: $9K published
Month from 1 Feb 2022: $510K published
Month from 1 Mar 2022: $39K published
Month from 1 Apr 2022: $2.6M published
Month from 1 Jul 2022: $284K published
Month from 1 Aug 2022: $13K published
Month from 1 Sep 2022: $7K published
Month from 1 Oct 2022: $12K published
Month from 1 Dec 2022: $15K published
Month from 1 Jan 2023: $0 published
Month from 1 Apr 2023: $683K published
Month from 1 Jun 2023: $31K published
Month from 1 Jul 2023: $13K published
Month from 1 Aug 2023: $14K published
Month from 1 Oct 2023: $44K published
Month from 1 Dec 2023: $12K published
Month from 1 Jan 2024: -$1K published
Month from 1 Feb 2024: $15K published
Month from 1 Apr 2024: $768K published
Month from 1 May 2024: -$165K published
Month from 1 Jul 2024: $8K published
Month from 1 Aug 2024: $21K published
Month from 1 Sep 2024: $98K published
Month from 1 Nov 2024: -$2K published
Month from 1 Dec 2024: $2K published
Month from 1 Jan 2025: -$108 published
Month from 1 May 2025: $503K published
Month from 1 Aug 2025: $244 published
Month from 1 Sep 2025: -$4K published
Month from 1 Nov 2025: $52K published
Month from 1 Mar 2026: -$790 published
Month from 1 Apr 2026: $727K published
Month from 1 May 2026: $484K published
Month from 1 Jun 2026: $382 published
Month from 1 Sep 2026: $35K published
Month from 1 Oct 2026: -$82K published
Month from 1 Nov 2026: $0 published
Lobbying spend
Quarter from 1 Jan 2022: $150K published
Quarter from 1 Apr 2022: $140K published
Quarter from 1 Jul 2022: $140K published
Quarter from 1 Oct 2022: $170K published
Quarter from 1 Jan 2023: $140K published
Quarter from 1 Oct 2026: $150K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $653K (13 May 2026), higher than 99% of its own history.
  • Insider net buying (open market): Insiders sold a net $1.7M in the last 12 months (the 12 months before: -$483K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 52 published in the last 12 months, -62% on the 12 months before.
  • Revenue per quarter: Revenue $2.4B in the latest quarter, -0.4% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 13 May 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 May 2026Frank A DamelioDirectorBuy6,650$75.39$501KForm 4
13 May 2026Paul BisaroDirectorBuy2,000$75.88$152KForm 4
12 May 2026Michael B McCallisterDirectorBuy3,000$77.76$233KForm 4
17 Feb 2026Kristin C PeckChief Executive OfficerSellplanned in advance (10b5-1); after exercising options20,000$127.05$2.5MForm 4
4 Jun 2025Roxanne LaganoExecutive Vice PresidentSellplanned in advance (10b5-1)652$170.00$111KForm 4
11 Mar 2025Roxanne LaganoExecutive Vice PresidentSellplanned in advance (10b5-1)326$170.00$55KForm 4
11 Mar 2025Willie M ReedDirectorSell1,210$166.14$201KForm 4
20 Feb 2025Kristin C PeckChief Executive OfficerSellplanned in advance (10b5-1); after exercising options382$156.68$60KForm 4

1,341 institutions reported shares at the end of Q3 2026, 93% of the shares outstanding; 117 opened a position, 190 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.38.5M9.48%$2.7B-902K-2.3%
Vanguard Capital Management LLC25.7M6.33%$1.8B-321K-1.2%
Vanguard Portfolio Management LLC23.5M5.78%$1.6B-355K-1.5%
State Street Corp19.7M4.85%$1.4B+38K+0.2%
State Farm Mutual Automobile Insurance Co15.9M3.91%$1.1BNo change
Geode Capital Management, LLC13.3M3.27%$923.7M-17K-0.1%
FIL Ltd10.6M2.62%$743.1M+5.3M+98%
Morgan Stanley8.0M1.98%$560.6M-850K-9.6%
Invesco Ltd.8.0M1.96%$556.4M+2.4M+44%
Nordea Investment Management Ab6.3M1.55%$443.0M-286K-4.3%

Federal contracts

All 4 federal contracts

No new award in 12 months; the latest was signed 14 Apr 2022. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
14 Apr 2022Department of AgricultureAnimal and Plant Health Inspection Service$2.6MCLASSICAL SWINE FEVER VIRUS (CSFV) VACCINE, DIVA, SUITABLE FOR USE IN VACCINATION PROGRAMS THAT EMPLOY DIFFERENTIATING INFECTED FROM VACCINATED ANIMALS TECHNIQUESUSAspending
1 Jul 2019Department of AgricultureAnimal and Plant Health Inspection Service$2.8MZOETIS: DIVA CTR AG-6395-C-14-0110 OPTION YEAR 4 - CSF DIVA VACCINEUSAspending
16 May 2016Department of AgricultureAnimal and Plant Health Inspection ServiceH5N1 AVIAN FLU VACCINE HPAI IGF::OT::IGFUSAspending
30 Sep 2014Department of AgricultureAnimal and Plant Health Inspection ServiceCLASSICAL SWINE FEVER VACCINE (DIVA) COMPATIBLE IGF::OT::IGFUSAspending

Company events

All 31 company events

In 12 months: 3 director or officer changes, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
13 Oct 2026Director or officer change8-K
6 Aug 2026Director or officer change8-K
21 May 2026Director or officer changeSame filing: shareholder vote results8-K
18 Dec 2025Signed a major agreementSame filing: took on new debt, sold shares privately8-K
28 Oct 2025Director or officer change8-K
27 Aug 2025Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
22 May 2025Director or officer changeSame filing: shareholder vote results8-K
24 May 2024Director or officer change8-K

194 open postings; careers site tracked since 22 Nov 2026.

PostedJobLocation
22 Nov 2026or earlierSenior Technical Services VeterinarianUS AR Remote
22 Nov 2026or earlierQO Lab Analyst IV - VIIKalamazoo - Portage Road
22 Nov 2026or earlierSenior Procurement SpecialistKalamazoo - Kilgore Road
22 Nov 2026or earlierFacilities & Production Maintenance TechnicianSan Diego
22 Nov 2026or earlierAseptic Technician ICharles City
22 Nov 2026or earlierPackaging Specialist I (3rd Shift)Kalamazoo - Kilgore Road
22 Nov 2026or earlierPork Technical Services VeterinarianUS IL Remote
22 Nov 2026or earlierQuality Scientist ICharles City

Reported lobbying spend: $150K in Q3 2026, $140K in Q4 2022. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
20 Oct 2022EndedInvariant LLCfor Zoetis Inc.Monitor prevention of infectious disease; educate policymakers on companion and livestock animal health; monitor and educate lawmakers on emerging infectious disease; educate policymakers on the Animal Drug User Fee Act (ADUFA). Analyzed the impact that funding contained in PL 117-169, the InflationAgricultureFiling
10 Jul 2019NewInvariant LLCfor Zoetis Inc.Educate Members of Congress on the importance of animal health; support efforts to establish a vaccine bank at the US Department of Agriculture and prepare for prevention of emerging diseases; educate Members on issues important to the companion animal pet industry and livestock health.ANI, AgricultureFiling
15 Feb 2013NewWilliams And Jensen, PLLCfor ZoetisADUFA/AGDUFA Reauthorization; legislation pertaining to animal health and animal medicine; general tax issues.Agriculture, Taxation, Health issuesFiling
5 Feb 2013NewZoetis Inc.its own lobbyistsAntimicrobial use in livestock animals, Veterinary prescriptions, Animal Drug User Fees, Animal Generic Drug User Fees, Farm Bill, Tax, Food SafetyManufacturing, Taxation, Health issues, Budget, FOO, ANI, Labor, Pharmacy, CAWFiling
1 Oct 2010NewThe Russell Group, Inc.for ZoetisIssues related to animal health.Agriculture, ANIFiling

Layoff notices

All 1 layoff notices

No notice in 12 months; the latest is dated 1 Jun 2015. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Jun 2015Zoetis, Inc.Florham Park, NJ16511 Aug 2015Notice

The 5 newest of 399 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 13 Oct 2026Filings record

    Director or officer change

  2. 10 Aug 2026Institutional holdings record

    FLOSSBACH VON STORCH SE opened a $303.0M position (2026Q2 13F)

  3. 6 Aug 2026Filings record

    Director or officer change

  4. 21 May 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  5. 21 May 2026Filings record

    Director or officer change

  6. 14 May 2026Insiders change

    had 3 insiders buy $886K of its shares on the open market within 30 days (3 filings).

    Who bought: Mccallister Michael B, Bisaro Paul, Damelio Frank A.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $886K
    Window
    14 Apr 2026 to 14 May 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  7. 14 May 2026Insiders record

    DAMELIO FRANK A (director) bought 6,650 shares of ZTS ($501,344) (dated 13 May 2026)

  8. 14 May 2026Insiders record

    Bisaro Paul (director) bought 2,000 shares of ZTS ($151,760) (dated 13 May 2026)

  9. 13 May 2026Insiders record

    MCCALLISTER MICHAEL B (director) bought 3,000 shares of ZTS ($233,280) (dated 12 May 2026)

  10. 11 Mar 2026Short interest and volume change

    had 17.3M shares sold short in the 27 Feb 2026 report, 2.7× the same report last year.

    Same report last year: 6.5M; its normal report is 8.9M.

    See the evidence
    This period
    17.3M (the 27 Feb 2026 report)
    Normal report (median of 24 earlier)
    8.9M
    Typical spread (median absolute deviation)
    1.4M
    How far from its usual level
    +3.9
    Same report last year
    6.5M
    History used
    2,982 days
    2025-02-28: 6.5M2025-03-14: 7.1M2025-03-31: 6.9M2025-04-15: 7.7M2025-04-30: 9.3M2025-05-15: 10.2M2025-05-30: 10.5M2025-06-13: 8.7M2025-06-30: 9.2M2025-07-15: 7.9M2025-07-31: 6.9M2025-08-15: 6.6M2025-08-29: 7.8M2025-09-15: 9.2M2025-09-30: 8.0M2025-10-15: 8.7M2025-10-31: 11.1M2025-11-14: 8.3M2025-11-28: 9.2M2025-12-15: 10.9M2025-12-31: 13.7M2026-01-15: 15.6M2026-01-30: 14.1M2026-02-13: 16.3M2026-02-27: 17.3M
    the 27 Feb 2026 report24 earlier reportsnormal: 8.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 26 Feb 2026Short interest and volume change

    had 16.3M shares sold short in the 13 Feb 2026 report, 2.0× the same report last year.

    Same report last year: 8.2M; its normal report is 8.7M.

    See the evidence
    This period
    16.3M (the 13 Feb 2026 report)
    Normal report (median of 24 earlier)
    8.7M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +4.2
    Same report last year
    8.2M
    History used
    2,968 days
    2025-02-14: 8.2M2025-02-28: 6.5M2025-03-14: 7.1M2025-03-31: 6.9M2025-04-15: 7.7M2025-04-30: 9.3M2025-05-15: 10.2M2025-05-30: 10.5M2025-06-13: 8.7M2025-06-30: 9.2M2025-07-15: 7.9M2025-07-31: 6.9M2025-08-15: 6.6M2025-08-29: 7.8M2025-09-15: 9.2M2025-09-30: 8.0M2025-10-15: 8.7M2025-10-31: 11.1M2025-11-14: 8.3M2025-11-28: 9.2M2025-12-15: 10.9M2025-12-31: 13.7M2026-01-15: 15.6M2026-01-30: 14.1M2026-02-13: 16.3M
    the 13 Feb 2026 report24 earlier reportsnormal: 8.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 11 Feb 2026Short interest and volume change

    had 14.1M shares sold short in the 30 Jan 2026 report, 1.6× the same report last year.

    Same report last year: 8.6M; its normal report is 8.6M.

    See the evidence
    This period
    14.1M (the 30 Jan 2026 report)
    Normal report (median of 24 earlier)
    8.6M
    Typical spread (median absolute deviation)
    885K
    How far from its usual level
    +4.2
    Same report last year
    8.6M
    History used
    2,954 days
    2025-01-31: 8.6M2025-02-14: 8.2M2025-02-28: 6.5M2025-03-14: 7.1M2025-03-31: 6.9M2025-04-15: 7.7M2025-04-30: 9.3M2025-05-15: 10.2M2025-05-30: 10.5M2025-06-13: 8.7M2025-06-30: 9.2M2025-07-15: 7.9M2025-07-31: 6.9M2025-08-15: 6.6M2025-08-29: 7.8M2025-09-15: 9.2M2025-09-30: 8.0M2025-10-15: 8.7M2025-10-31: 11.1M2025-11-14: 8.3M2025-11-28: 9.2M2025-12-15: 10.9M2025-12-31: 13.7M2026-01-15: 15.6M2026-01-30: 14.1M
    the 30 Jan 2026 report24 earlier reportsnormal: 8.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 28 Jan 2026Short interest and volume change

    had 15.6M shares sold short in the 15 Jan 2026 report, 2.2× the same report last year.

    Same report last year: 7.1M; its normal report is 8.4M.

    See the evidence
    This period
    15.6M (the 15 Jan 2026 report)
    Normal report (median of 24 earlier)
    8.4M
    Typical spread (median absolute deviation)
    844K
    How far from its usual level
    +5.7
    Same report last year
    7.1M
    History used
    2,939 days
    2025-01-15: 7.1M2025-01-31: 8.6M2025-02-14: 8.2M2025-02-28: 6.5M2025-03-14: 7.1M2025-03-31: 6.9M2025-04-15: 7.7M2025-04-30: 9.3M2025-05-15: 10.2M2025-05-30: 10.5M2025-06-13: 8.7M2025-06-30: 9.2M2025-07-15: 7.9M2025-07-31: 6.9M2025-08-15: 6.6M2025-08-29: 7.8M2025-09-15: 9.2M2025-09-30: 8.0M2025-10-15: 8.7M2025-10-31: 11.1M2025-11-14: 8.3M2025-11-28: 9.2M2025-12-15: 10.9M2025-12-31: 13.7M2026-01-15: 15.6M
    the 15 Jan 2026 report24 earlier reportsnormal: 8.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 13 Jan 2026Short interest and volume change

    had 13.7M shares sold short in the 31 Dec 2025 report, 2.0× the same report last year.

    Same report last year: 7.0M; its normal report is 8.2M.

    See the evidence
    This period
    13.7M (the 31 Dec 2025 report)
    Normal report (median of 24 earlier)
    8.2M
    Typical spread (median absolute deviation)
    1.0M
    How far from its usual level
    +3.6
    Same report last year
    7.0M
    History used
    2,924 days
    2024-12-31: 7.0M2025-01-15: 7.1M2025-01-31: 8.6M2025-02-14: 8.2M2025-02-28: 6.5M2025-03-14: 7.1M2025-03-31: 6.9M2025-04-15: 7.7M2025-04-30: 9.3M2025-05-15: 10.2M2025-05-30: 10.5M2025-06-13: 8.7M2025-06-30: 9.2M2025-07-15: 7.9M2025-07-31: 6.9M2025-08-15: 6.6M2025-08-29: 7.8M2025-09-15: 9.2M2025-09-30: 8.0M2025-10-15: 8.7M2025-10-31: 11.1M2025-11-14: 8.3M2025-11-28: 9.2M2025-12-15: 10.9M2025-12-31: 13.7M
    the 31 Dec 2025 report24 earlier reportsnormal: 8.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 5 Nov 2025Institutional holdings record

    DIAMOND HILL CAPITAL MANAGEMENT INC opened a $394.0M position (2025Q3 13F)

  16. 28 Oct 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 28 Oct 2025Filings record

    Director or officer change

  18. 27 Aug 2025Filings record

    A major agreement ended

  19. 22 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 22 May 2025Filings record

    Director or officer change

  21. 12 Aug 2024Institutional holdings record

    Veritas Asset Management LLP opened a $402.0M position (2024Q2 13F)

  22. 11 Jul 2024Short interest and volume change

    had 6.2M shares sold short in the 28 Jun 2024 report, 2.5× the same report last year.

    Same report last year: 2.5M; its normal report is 3.5M.

    See the evidence
    This period
    6.2M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    388K
    How far from its usual level
    +4.9
    Same report last year
    2.5M
    History used
    2,373 days
    2023-06-30: 2.5M2023-07-14: 2.8M2023-07-31: 3.5M2023-08-15: 3.8M2023-08-31: 3.7M2023-09-15: 3.5M2023-09-29: 2.9M2023-10-13: 3.0M2023-10-31: 3.1M2023-11-15: 3.0M2023-11-30: 3.3M2023-12-15: 3.7M2023-12-29: 3.0M2024-01-12: 2.7M2024-01-31: 3.0M2024-02-15: 3.4M2024-02-29: 3.8M2024-03-15: 3.6M2024-03-28: 3.7M2024-04-15: 3.2M2024-04-30: 5.2M2024-05-15: 6.0M2024-05-31: 5.8M2024-06-14: 6.9M2024-06-28: 6.2M
    the 28 Jun 2024 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 27 Jun 2024Short interest and volume change

    had 6.9M shares sold short in the 14 Jun 2024 report, 2.2× the same report last year.

    Same report last year: 3.2M; its normal report is 3.4M.

    See the evidence
    This period
    6.9M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    3.4M
    Typical spread (median absolute deviation)
    357K
    How far from its usual level
    +6.6
    Same report last year
    3.2M
    History used
    2,359 days
    2023-06-15: 3.2M2023-06-30: 2.5M2023-07-14: 2.8M2023-07-31: 3.5M2023-08-15: 3.8M2023-08-31: 3.7M2023-09-15: 3.5M2023-09-29: 2.9M2023-10-13: 3.0M2023-10-31: 3.1M2023-11-15: 3.0M2023-11-30: 3.3M2023-12-15: 3.7M2023-12-29: 3.0M2024-01-12: 2.7M2024-01-31: 3.0M2024-02-15: 3.4M2024-02-29: 3.8M2024-03-15: 3.6M2024-03-28: 3.7M2024-04-15: 3.2M2024-04-30: 5.2M2024-05-15: 6.0M2024-05-31: 5.8M2024-06-14: 6.9M
    the 14 Jun 2024 report24 earlier reportsnormal: 3.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 12 Jun 2024Short interest and volume change

    had 5.8M shares sold short in the 31 May 2024 report, 1.6× the same report last year.

    Same report last year: 3.6M; its normal report is 3.4M.

    See the evidence
    This period
    5.8M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    3.4M
    Typical spread (median absolute deviation)
    335K
    How far from its usual level
    +4.9
    Same report last year
    3.6M
    History used
    2,345 days
    2023-05-31: 3.6M2023-06-15: 3.2M2023-06-30: 2.5M2023-07-14: 2.8M2023-07-31: 3.5M2023-08-15: 3.8M2023-08-31: 3.7M2023-09-15: 3.5M2023-09-29: 2.9M2023-10-13: 3.0M2023-10-31: 3.1M2023-11-15: 3.0M2023-11-30: 3.3M2023-12-15: 3.7M2023-12-29: 3.0M2024-01-12: 2.7M2024-01-31: 3.0M2024-02-15: 3.4M2024-02-29: 3.8M2024-03-15: 3.6M2024-03-28: 3.7M2024-04-15: 3.2M2024-04-30: 5.2M2024-05-15: 6.0M2024-05-31: 5.8M
    the 31 May 2024 report24 earlier reportsnormal: 3.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 25 May 2024Short interest and volume change

    had 6.0M shares sold short in the 15 May 2024 report, 1.6× the same report last year.

    Same report last year: 3.7M; its normal report is 3.4M.

    See the evidence
    This period
    6.0M (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    3.4M
    Typical spread (median absolute deviation)
    329K
    How far from its usual level
    +5.4
    Same report last year
    3.7M
    History used
    2,329 days
    2023-05-15: 3.7M2023-05-31: 3.6M2023-06-15: 3.2M2023-06-30: 2.5M2023-07-14: 2.8M2023-07-31: 3.5M2023-08-15: 3.8M2023-08-31: 3.7M2023-09-15: 3.5M2023-09-29: 2.9M2023-10-13: 3.0M2023-10-31: 3.1M2023-11-15: 3.0M2023-11-30: 3.3M2023-12-15: 3.7M2023-12-29: 3.0M2024-01-12: 2.7M2024-01-31: 3.0M2024-02-15: 3.4M2024-02-29: 3.8M2024-03-15: 3.6M2024-03-28: 3.7M2024-04-15: 3.2M2024-04-30: 5.2M2024-05-15: 6.0M
    the 15 May 2024 report24 earlier reportsnormal: 3.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 24 May 2024Filings record

    Director or officer change

  27. 23 May 2024Filings record

    Director or officer change

  28. 10 May 2024Short interest and volume change

    had 5.2M shares sold short in the 30 Apr 2024 report, 1.1× the same report last year.

    Same report last year: 4.6M; its normal report is 3.4M.

    See the evidence
    This period
    5.2M (the 30 Apr 2024 report)
    Normal report (median of 24 earlier)
    3.4M
    Typical spread (median absolute deviation)
    329K
    How far from its usual level
    +3.7
    Same report last year
    4.6M
    History used
    2,314 days
    2023-04-28: 4.6M2023-05-15: 3.7M2023-05-31: 3.6M2023-06-15: 3.2M2023-06-30: 2.5M2023-07-14: 2.8M2023-07-31: 3.5M2023-08-15: 3.8M2023-08-31: 3.7M2023-09-15: 3.5M2023-09-29: 2.9M2023-10-13: 3.0M2023-10-31: 3.1M2023-11-15: 3.0M2023-11-30: 3.3M2023-12-15: 3.7M2023-12-29: 3.0M2024-01-12: 2.7M2024-01-31: 3.0M2024-02-15: 3.4M2024-02-29: 3.8M2024-03-15: 3.6M2024-03-28: 3.7M2024-04-15: 3.2M2024-04-30: 5.2M
    the 30 Apr 2024 report24 earlier reportsnormal: 3.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 7 May 2024Institutional holdings record

    JENSEN INVESTMENT MANAGEMENT INC opened a $266.0M position (2024Q1 13F)

  30. 16 Apr 2024Filings record

    Director or officer change

  31. 1 Apr 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 1 Apr 2024Filings record

    Director or officer change

  33. 13 Nov 2023Institutional holdings record

    GQG Partners LLC opened a $318.0M position (2023Q3 13F)

  34. 15 May 2023Institutional holdings change

    saw 125 13F filers open a new position in the quarter ended 31 Mar 2023, 1.2× the same quarter last year.

    Same quarter last year: 100; its normal quarter is 87.

    See the evidence
    This period
    125 (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    87
    Typical spread (median absolute deviation)
    5
    How far from its usual level
    +4.4
    Same quarter last year
    100
    History used
    3,469 days
    2021-03-31: 872021-06-30: 952021-09-30: 852021-12-31: 1272022-03-31: 1002022-06-30: 872022-09-30: 742022-12-31: 852023-03-31: 125
    the quarter ended 31 Mar 20238 earlier quartersnormal: 87

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  35. 7 Feb 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 7 Feb 2023Filings record

    Director or officer change

  37. 21 Dec 2022Filings record

    A major agreement ended

  38. 15 Dec 2022Lobbying record

    ZOETIS INC.: lobbying engagement terminated (INVARIANT LLC) (dated 20 Oct 2022)

  39. 25 Oct 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 25 Oct 2022Filings record

    Director or officer change

Showing the newest 40 of 80 entries; narrow the window or the kind of data to see older ones.

Not listed: 278 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001555280
Ticker
ZTS
Domain
zoetis.com
Employer name
ZOETIS, INC. (1 unverified)
Hq location
NJ|PARSIPPANY|07054 (1 unverified)
Lobbying client
zoetis
Name
Abaxis Europe GmbH, Abaxis, Inc, Adivo GmbH, Alpharma (Bermuda), LLC and 100 more
Uei
MXRTXKG318E5
Wikidata
Q8073337
Wikipedia
Zoetis
  • DOL H-1B labor condition applications and PERM certifications1030 data points1 Oct 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)5 records, 150 data points1 Oct 2010 to 30 Sep 2026
  • SEC Form 13F institutional holdings10 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)137 records5 Jan 2016 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)969 data points31 Dec 2010 to 30 Oct 2026
  • SEC Form 4 insider transactions173 records, 588 data points10 May 2016 to 13 May 2026
  • FINRA short interest (twice monthly)627 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards4 records, 1026 data points18 Apr 2014 to 30 Oct 2026
  • WARN layoff notices (state labor agencies)1 record, 3 data points1 Jun 2015 to 1 Jun 2015
  • Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026